At a glance
- Originator Bristol-Myers Squibb
- Class Antivirals; Organic chemicals
- Mechanism of Action HIV protease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 02 Dec 1998 Phase-I clinical trials for HIV infections treatment in USA (Unknown route)
- 02 May 1997 Preclinical development for HIV infections treatment in USA (Unknown route)